Genmab (Suzhou) Co., Ltd. (legal name: 健瑞楠生物制药(苏州)有限公司) is the China-based subsidiary of Genmab, a biotechnology company focused on antibody therapeutics. Located in Suzhou, Jiangsu, the company supports the research and development of biologic medicines, with an emphasis on oncology and immune-related diseases.
The Suzhou operation contributes to discovery and preclinical research, process and analytical development, and clinical development activities in China, including trial execution and regulatory support. Its work spans monoclonal and bispecific antibodies and related biologics, aligning with Genmab’s global pipeline and partnerships.
None yet. When a new project in the record names Genmab (Suzhou) Co., Ltd. as owner, partner or investor, it shows here.
Genmab shifts focus to high-impact projects in its late-stage pipeline, ensuring no change to 2025 financial guidance.
